Original Article

Epidemiological, Demographic, and Clinical Characteristics of Von Willebrand Disease Patients in Zahedan City, Iran: A Descriptive Study

Abstract

Background: Von Willebrand disease (VWD) is one of the most common coagulative diseases, so identifying the effective factors in preventing this complication is essential. This study aims to evaluate the frequency of demographic and epidemiological findings in VWD patients referred to a hospital in Zahedan, Iran.
Materials and Methods: This study was performed on 76 patients with VWD referred to Hazrat Ali-Asghar Hospital in Zahedan City, Sistan, and Baluchestan province. After obtaining consent from the patients, the demographic information and clinical symptoms of the disease were recorded. All statistical analyses were performed using SPSS 22.0 software. All descriptive data were expressed as mean ±SD and percent (%) depending on the continuous and dichotomous variables. A P-value ≤0.05 was considered significant statistically.

Results: The present study results showed that the highest age group of VWD patients at the time of disease diagnosis was in the age group 1-5 years (47.3%), and most patients had type III VWD (80.3%). It was also found that 67.1% of patients had a positive family history and their parents' consanguineous marriage (77.6%). The most common complaints were epistaxis (88.15%), cutaneous bleeding (78.94%), and oral cavity bleeding (61.84%), respectively.
Conclusion: Due to the high prevalence of VWD in consanguineous marriages and an increase in adverse complications and symptoms in VWD patients, the proper diagnosis and screening at an early age, especially in people with family history, is essential. Efforts are needed to develop national registries and widely provide the required and available basic services for diagnosis and treatment.

1. Lenting P, Casari C, Christophe O, Denis C. von Willebrand factor: The old, the new and the unknown. J Thromb Haemost. 2012; 10(12):2428-37.
2. Stufano F, Boscarino M, Bucciarelli P, et al. Evaluation of the utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome. Semin Thromb Hemost. 2019;45(1):36-42.
3. Zakiani Roudsari M, Shahbazi S, Mahdian R, et al. vWF gene expression analysis in type3 von willebrand affected patients using real-time PCR. Sci J Iran Blood Transfus Organ. 2013;9(4):391-8.
4. Favaloro EJ. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays. Blood Coagul Fibrinolysis. 2011;22(7):553-64.
5. Connell NT, James PD, Brignardello-Petersen R, et al. von Willebrand disease: proposing definitions for future research. Blood Adv. 2021;5(2):565-569.
6. Bharati KP, Prashanth UR. Von Willebrand disease: an overview. Indian J Pharm Sci. 2011;73(1):7-16.
7. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003;101(6):2089-93.
8. Abdoli T, Samimi M, Atoof F, et al. Prevalence of Von Willebrand Disease in Women of Reproductive Age With Heavy Menstrual Bleeding in Kashan, Iran, During 2019. Int J Epidemiol Res. 2020;7(4):163-6.
9. Meyer D, Fressinaud E, Hilbert L,et al. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Pract Res Clin Haematol. 2001;14(2):349-64.
10. Federici AB, Lee CA, Berntorp EE, Lillicrap D, Montgomery RR (eds). Von Willebrand Disease: Basic and Clinical Aspects. Wiley-Blackwell: Oxford, UK, 2011, pp 77-83.
11.Baronciani L, Cozzi G, Canciani MT, et al. Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease. Thromb Haemost. 2000;84(4):536-40.
12. Roberts J, Flood V. Laboratory diagnosis of von Willebrand disease. Int J Lab Hematol. 2015;37 Suppl 1(Suppl 1):11-7.
13. Hussain LF, Abid OA. Congenital von Willebrand factor deficiency in single Iraqi teaching hospital: A descriptive study. Iraqi J Hematol. 2016;5(2):154-156.
14. Khan MK, Khan SQ, Malik NA. Spectrum of Von Willebrand’s disease in Punjab: clinical features and types. J Ayub Med Coll Abbottabad. 2014;26(4):470-3.
15. Mohsin S. Clinical manifestations and complications of von Willebrand disease. JRMC. 2012;16(1):19-21.
16. Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost. 2005;31(5):569-76.
17. Karimi M, Yarmohammadi H, Ardeshiri R, Yarmohammadi H. Inherited coagulation disorders in southern Iran. Haemophilia. 2002;8(6):740-4.
18. Hussain MS, Nair A, Kumar G, et al. Reconstruction of infra orbital rim with rib cartilage. Indian J Dent Res. 2019;30(1):154-156.
19. Payandeh M, Rahimi Z, Kansestani AN, et al. Clinical features and types of von Willebrand disease in women with menorrhagia referred to hematology clinic of kermanshah. Int J Hematol Oncol Stem Cell Res. 2013;7(2):1-5.
20. Borhany M, Shamsi T, Naz A, et al. Clinical features and types of von Willebrand disease in Karachi. Clin Appl Thromb Hemost. 2011;17(6):E102-5.
Files
IssueVol 18 No 3 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijhoscr.v18i3.16102
Keywords
Von willebrand disease Demographics Epidemiologic Clinical
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Naderi M, Rhmati B, Ganjali H, Yaghoubi S, Harifi-Mood MS, Azizi SG. Epidemiological, Demographic, and Clinical Characteristics of Von Willebrand Disease Patients in Zahedan City, Iran: A Descriptive Study. Int J Hematol Oncol Stem Cell Res. 2024;18(3):220-226.